Relevant studies have reported that SULT1A3 may be a diagnostic marker for osteosarcoma, and SULT1A3 protein upregulation is closely related to the occurrence and development of cancer (Chen et al., 2014a; Chen et al., 2014b; Xie et al., 2017). The gene discussed is SULT1A3; the disease is cancer.